VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $838 | -69.6% | 89,451 | -24.4% | 0.01% | -68.8% |
| Q1 2023 | $2,753 | +1529.0% | 118,317 | +1675.7% | 0.03% | +1500.0% |
| Q4 2022 | $169 | -99.9% | 6,663 | -42.8% | 0.00% | -33.3% |
| Q3 2022 | $225,000 | -26.0% | 11,647 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $304,000 | -65.0% | 11,929 | -64.7% | 0.00% | -50.0% |
| Q1 2022 | $868,000 | +648.3% | 33,751 | +1115.8% | 0.01% | +500.0% |
| Q4 2021 | $116,000 | -95.6% | 2,776 | -95.4% | 0.00% | -91.7% |
| Q3 2021 | $2,617,000 | +50.8% | 60,131 | +63.8% | 0.01% | +50.0% |
| Q2 2021 | $1,735,000 | -19.3% | 36,704 | -12.5% | 0.01% | -27.3% |
| Q1 2021 | $2,150,000 | +248.5% | 41,927 | +81.9% | 0.01% | +266.7% |
| Q4 2020 | $617,000 | -38.8% | 23,051 | -6.4% | 0.00% | -62.5% |
| Q2 2020 | $1,008,000 | – | 24,614 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |